The World Health Organization (WHO) refers to obesity as abnormal or excessive fat
accumulation that presents a health risk. Obesity was first designated as a disease in 2012 …

Abstract Purpose of Review Anti-hypertensive and lipid lowering therapy addresses only
half of the cardiovascular disease risk in patients with body mass index> 30 kg/m2, ie …

Obesity and hypertension, independently and combined, are associated with increased risk
of heart failure and heart failure-related morbidity and mortality. Interest in circulating …

Type 2 diabetes is often complicated with hypertension, such that 73.6% of patients≥ 18
years with type 2 diabetes also have hypertension. With increasing age, the risk of …

Abstract Background and Aims Randomized clinical trials (RCTs) assessing semaglutide
reported reductions of systolic blood pressure (SBP) in trial populations with baseline blood …

Background and Objectives: Gestational hypertension has been associated with several
pregnancy short-term and long-term complications, affecting both the mother and her infant's …

Background The gut and gut microbiota, which were previously neglected in blood pressure
regulation, are becoming increasingly recognized as factors contributing to hypertension …

This study investigated the relationship between obesity and hypertension from a public
health perspective in a small remote island of Okinawa where obesity is prevalent. A cross …

Obesity is becoming increasingly prevalent in China and worldwide and is closely related to
the development of hypertension. The pathophysiology of obesity-associated hypertension …

Objective Hypertension (HTN) is a prevalent global health concern. From the standpoint of
preventive and personalized medicine (PPPM/3PM), early detection of HTN offers a crucial …